Outcomes {12}
viral suppression
SECONDARY
The primary outcome of this trial is viral suppression at 18 months, comparing (i) all individuals randomized to clinic-based care with or without lottery incentives for the full 18 months and (ii) nonresponding individuals rerandomized to home- or community-based care to those rerandomized to clinic-based care. The secondary outcomes are (a) retention in care (defined as the proportion of clinical visits and medication refills missed over the last 12 months of the intervention) and (b) time to ART initiation, and additional analyses will include (c) impact of the adaptive interventions among men; (d) impact among the two subgroups at enrollment (persons with detectable viral load and persons not engaged in care); (e) assessment of how baseline variables influence the difference between adaptive interventions; and (f) comparison of viral suppression and retention outcomes between local clinics. For home delivery, missed ART deliveries, total miles traveled, and CO